EBISTRIDE
Swiss trademark · 615471 · Word mark · Deleted
Register entry
- Registration number
- 615471
- Application number
- 51161/2011
- Status
- Deleted
- Type
- Word mark
- Filed
- Feb 1, 2011
- Registered
- May 18, 2011
- Published
- May 18, 2011
- Deleted
- Aug 25, 2021
- Reason
- Not renewed
- Priority
- 02.09.2010 US
- Source
- Swissreg
Goods and services
Pharmaceuticals
Pharmazeutische Präparate zur Anwendung beim Menschen für die Behandlung oder Prävention von metabolischen Störungen.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 25, 2021
Deleted, not renewed
Published in Swissreg on 25.08.2021
- Oct 6, 2020
Agent’s address changed
- Representative
- Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49, Postfach, 8027 Zürich → Keller Schneider Patent- und Markenanwälte AG (Zürich), Beethovenstrasse 49, Postfach, 8027 Zürich
Published in Swissreg on 06.10.2020
- Apr 19, 2017
Agent’s address changed
- Representative
- Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49,, Postfach 2792, 8022 Zürich → Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49, Postfach, 8027 Zürich
Published in Swissreg on 19.04.2017
- May 6, 2014
Transferred
- Owner
- Bristol-Myers Squibb Company, 345 Park Avenue, New York, NY 10154, USA → AstraZeneca AB, Vastra Malarehamnen 9, 15185 Södertälje, Sweden
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49,, Postfach 2792, 8022 Zürich
Published in Swissreg on 06.05.2014
- May 18, 2011
Registered
Published in Swissreg on 18.05.2011
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.